Glatiramer acetate (Copaxone) side effects
A study shows that the new three times a week version of Copaxone caused about half the number of injection site reactions than the daily version. Reported at the ACTRIMS/ECTRIMS conference.
Teva press release
Glatiramer acetate (Copaxone) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news